
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia
Xiu Liu, Qiulan Lv, Hongyan Ren, et al.
PeerJ (2020) Vol. 8, pp. e8664-e8664
Open Access | Times Cited: 83
Xiu Liu, Qiulan Lv, Hongyan Ren, et al.
PeerJ (2020) Vol. 8, pp. e8664-e8664
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies
Jing Wang, Yong Chen, Hao Zhong, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 14, pp. 3979-3989
Closed Access | Times Cited: 210
Jing Wang, Yong Chen, Hao Zhong, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 14, pp. 3979-3989
Closed Access | Times Cited: 210
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Sidar Çöpür, Atalay Demiray, Mehmet Kanbay
European Journal of Internal Medicine (2022) Vol. 103, pp. 4-12
Closed Access | Times Cited: 159
Sidar Çöpür, Atalay Demiray, Mehmet Kanbay
European Journal of Internal Medicine (2022) Vol. 103, pp. 4-12
Closed Access | Times Cited: 159
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 90
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 90
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access | Times Cited: 9
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access | Times Cited: 9
Lactic acid bacteria strains relieve hyperuricaemia by suppressing xanthine oxidase activityviaa short-chain fatty acid-dependent mechanism
Caixin Ni, Xin Li, Linlin Wang, et al.
Food & Function (2021) Vol. 12, Iss. 15, pp. 7054-7067
Closed Access | Times Cited: 84
Caixin Ni, Xin Li, Linlin Wang, et al.
Food & Function (2021) Vol. 12, Iss. 15, pp. 7054-7067
Closed Access | Times Cited: 84
Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts
Jie Wei, Yuqing Zhang, Nicola Dalbeth, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 4, pp. 682-691
Closed Access | Times Cited: 76
Jie Wei, Yuqing Zhang, Nicola Dalbeth, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 4, pp. 682-691
Closed Access | Times Cited: 76
Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid
Keisuke Sato, Kyoko Yamazaki, Tamotsu Kato, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 60
Keisuke Sato, Kyoko Yamazaki, Tamotsu Kato, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 60
Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components
Chengyuan Wang, Dai Jian-gang
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 28
Chengyuan Wang, Dai Jian-gang
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 28
A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Cichorium intybus L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats
Mukaram Amatjan, Na Li, Pengke He, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 107-128
Open Access | Times Cited: 24
Mukaram Amatjan, Na Li, Pengke He, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 107-128
Open Access | Times Cited: 24
Nickel exposure induces gut microbiome disorder and serum uric acid elevation
Jinfeng Yang, Pengya Feng, Zhenmin Ling, et al.
Environmental Pollution (2023) Vol. 324, pp. 121349-121349
Closed Access | Times Cited: 24
Jinfeng Yang, Pengya Feng, Zhenmin Ling, et al.
Environmental Pollution (2023) Vol. 324, pp. 121349-121349
Closed Access | Times Cited: 24
Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions
Qingqing Han, Qi-dong Ren, Xu Guo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 13
Qingqing Han, Qi-dong Ren, Xu Guo, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 13
Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome
Xinghong Zhou, Shuai Ji, Liqian Chen, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Xinghong Zhou, Shuai Ji, Liqian Chen, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Probiotics with ABCG2 expression ability and gut microbiota homeostasis exhibit anti-hyperuricemia potential by promoting uric acid excretion
Yuting Fan, Liuying Li, Philippe Madjirebaye, et al.
Journal of Functional Foods (2025) Vol. 128, pp. 106814-106814
Closed Access | Times Cited: 1
Yuting Fan, Liuying Li, Philippe Madjirebaye, et al.
Journal of Functional Foods (2025) Vol. 128, pp. 106814-106814
Closed Access | Times Cited: 1
Swine gut microbiota and its interaction with host nutrient metabolism
Hongyu Wang, Rongying Xu, He Zhang, et al.
Animal nutrition (2020) Vol. 6, Iss. 4, pp. 410-420
Open Access | Times Cited: 67
Hongyu Wang, Rongying Xu, He Zhang, et al.
Animal nutrition (2020) Vol. 6, Iss. 4, pp. 410-420
Open Access | Times Cited: 67
Impact of Camellia japonica Bee Pollen Polyphenols on Hyperuricemia and Gut Microbiota in Potassium Oxonate-Induced Mice
Yuanyuan Xu, Xirong Cao, Haoan Zhao, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2665-2665
Open Access | Times Cited: 56
Yuanyuan Xu, Xirong Cao, Haoan Zhao, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2665-2665
Open Access | Times Cited: 56
Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism
Eder Orlando Méndez-Salazar, Janitzia Vázquez‐Mellado, Carlos S. Casimiro‐Soriguer, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 52
Eder Orlando Méndez-Salazar, Janitzia Vázquez‐Mellado, Carlos S. Casimiro‐Soriguer, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 52
Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 43
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 43
Usefulness of Extra Virgin Olive Oil Minor Polar Compounds in the Management of Chronic Kidney Disease Patients
Annalisa Noce, Giulia Marrone, Silvia Urciuoli, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 581-581
Open Access | Times Cited: 42
Annalisa Noce, Giulia Marrone, Silvia Urciuoli, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 581-581
Open Access | Times Cited: 42
Folic Acid Protects against Hyperuricemia in C57BL/6J Mice via Ameliorating Gut–Kidney Axis Dysfunction
Peng Wang, Xiao‐Qi Zhang, Xian Zheng, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 50, pp. 15787-15803
Closed Access | Times Cited: 37
Peng Wang, Xiao‐Qi Zhang, Xian Zheng, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 50, pp. 15787-15803
Closed Access | Times Cited: 37
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development
Hye Won Kim, Eun-Jeong Yoon, Seok Hoon Jeong, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 3, pp. 241-241
Open Access | Times Cited: 31
Hye Won Kim, Eun-Jeong Yoon, Seok Hoon Jeong, et al.
Yonsei Medical Journal (2022) Vol. 63, Iss. 3, pp. 241-241
Open Access | Times Cited: 31
Potential Probiotic Lacticaseibacillus paracasei MJM60396 Prevents Hyperuricemia in a Multiple Way by Absorbing Purine, Suppressing Xanthine Oxidase and Regulating Urate Excretion in Mice
Youjin Lee, Pia Werlinger, Joo‐Won Suh, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 851-851
Open Access | Times Cited: 31
Youjin Lee, Pia Werlinger, Joo‐Won Suh, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 851-851
Open Access | Times Cited: 31
Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid
Shuai Zhao, Pengya Feng, Xiaogang Hu, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105198-105198
Open Access | Times Cited: 30
Shuai Zhao, Pengya Feng, Xiaogang Hu, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105198-105198
Open Access | Times Cited: 30
The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29